GENO.STGENO.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.31% | -19.38% | -2.03% | -16.30% | +44.09% |
| Gross Profit Growth | +1025.09% | +98.96% | +947.62% | -14.04% | +45.44% |
| EBITDA Growth | +19.43% | -49.75% | +14.84% | -72.00% | +51.04% |
| Operating Income Growth | +143.56% | -56.14% | +37.35% | -84.70% | +51.27% |
| Net Income Growth | +0.00% | -72.88% | +185.87% | -41.83% | +50.43% |
| EPS Growth | +0.00% | -72.21% | +186.45% | -42.86% | +42.65% |
| EPS Diluted Growth | +0.00% | -72.21% | +186.45% | -42.86% | +42.65% |
| Weighted Average Shares Growth | +0.00% | +0.00% | +0.00% | +0.91% | +0.91% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | +0.00% | +0.91% | +0.91% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +88.47% | -41.12% | +0.00% | +1404.15% | -14.53% |
| Free Cash Flow Growth | +120.33% | -40.03% | +0.00% | -100.00% | -100.00% |
| Receivables Growth | +21.35% | +0.00% | +0.00% | +0.00% | -100.00% |
| Inventory Growth | -9.84% | +0.00% | +0.00% | +0.00% | -100.00% |
| Asset Growth | +13.35% | +8.79% | +10.10% | +14.61% | +15.43% |
| Book Value per Share Growth | +19.48% | +13.37% | +15.02% | +17.53% | +18.03% |
| Debt Growth | -3.43% | -3.81% | +5.26% | +108.06% | +82.55% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -0.38% | -8.63% | -100.00% | -100.00% | -100.00% |